Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Adam

Showing results (1021-1030 of 1,391) with videos related to

Pageof 140
Sort By:
Antimicrobial Agents and Chemotherapy|August 28, 2013
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance studyJames A Karlowsky, Heather J Adam, Melanie R Baxter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapyGilles Crehange, Devan Krishnamurthy, J Adam Cunha, et al.
Leukemia|December 28, 2016
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivoS Hipp, Y-T Tai, D Blanset, et al.
Nuclear Medicine and Biology|July 16, 2016
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)YEric W Price, Kimberly J Edwards, Kathryn E Carnazza, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23)Melissa McCracken, Andrew Walkty, Heather J Adam, et al.
Leukemia|July 29, 2017
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivoS Hipp, Y-T Tai, D Blanset, et al.
Antimicrobial Agents and Chemotherapy|December 2, 2009
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006Heather J Adam, Lisa Louie, Christine Watt, et al.
Archives of General Psychiatry|August 6, 1999
Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperoneL N Yatham, P F Liddle, J Dennie, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 2, 2010
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depressionLakshmi N Yatham, Peter F Liddle, Raymond W Lam, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategyAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Pageof 140

Showing results (1021-1030 of 1,391) with videos related to

Sort By:
Pageof 140
Antimicrobial Agents and Chemotherapy|August 28, 2013
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance studyJames A Karlowsky, Heather J Adam, Melanie R Baxter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapyGilles Crehange, Devan Krishnamurthy, J Adam Cunha, et al.
Leukemia|December 28, 2016
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivoS Hipp, Y-T Tai, D Blanset, et al.
Nuclear Medicine and Biology|July 16, 2016
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)YEric W Price, Kimberly J Edwards, Kathryn E Carnazza, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23)Melissa McCracken, Andrew Walkty, Heather J Adam, et al.
Leukemia|July 29, 2017
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivoS Hipp, Y-T Tai, D Blanset, et al.
Antimicrobial Agents and Chemotherapy|December 2, 2009
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006Heather J Adam, Lisa Louie, Christine Watt, et al.
Archives of General Psychiatry|August 6, 1999
Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperoneL N Yatham, P F Liddle, J Dennie, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 2, 2010
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depressionLakshmi N Yatham, Peter F Liddle, Raymond W Lam, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategyAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Pageof 140